ClearPoint Neuro, Inc. (CLPT) Misses Q3 EPS by 3c

ClearPoint Neuro, Inc. (NASDAQ: CLPT) reported Q3 EPS of ($0.21), $0.03 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $8.86 million versus the consensus estimate of $9.8 million.

For earnings history and earnings-related data on ClearPoint Neuro, Inc. (CLPT) click here.

You May Also Be Interested In

• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Bernstein SocGen Highlights an 'Enhanced Buying Opportunity' at CRH plc (CRH)
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity